Pharyngeal mucositis and esophagitis after re-irradiation spine stereotactic body radiotherapy with 24 Gy in two fractions
Grade ≥ 3 pharyngeal mucositis and esophagitis were rare; the current dose constraints are safe for re-irradiated spine SBRT. Reducing the pharyngeal and esophageal maximum doses may be helpful among patients for whom avoiding symptomatic mucositis is particularly important.
Authors
- Y. Nakajima (ORCID: https://orcid.org/0000-0001-9317-6299)
- Kentaro Taguchi (ORCID: https://orcid.org/0000-0002-9018-9112)
- Keiko Nemoto Murofushi
- Kei Ito
Institutions
- Tokyo Metropolitan Komagome Hospital (JP)
- Komazawa University (JP)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1016/j.ctro.2025.101100
- Primary Topic
- Management of metastatic bone disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00